Arcus Biosciences (RCUS) PT Lowered to $47 at Leerink Partners
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NYSE: RCUS) | Delayed: 19.14 +0.23 (1.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.91 | 52 Week High | $ | |||
| Open | $19.51 | 52 Week Low | $ | |||
| Day High | $19.63 | P/E | N/A | |||
| Day Low | $18.60 | EPS | $ | |||
| Volume | 704,356 | |||||
